Not logged inSafety and Tolerability of Relugolix in Combination with Abiraterone or Apalutamide for Treatment of Patients with Advanced Prostate Cancer: Data from a 52-Week Clinical Trial
De La Cerda, Jose; Belkoff, Laurence; Courtney, Kevin D.; Diamond, Elan; D'Olimpio, James; Dunshee, Curtis; Gervasi, Lawrence; Goodman, Michael; Mittal, Kriti; Morris, David; Sieber, Paul; Tutrone, Ronald; Ryan, Michael; Zhong, Yi; Ufer, Mike; Shore, Neal .png)
Share.png)
SaveImplementing evidence-based strategies for men with biochemically recurrent and advanced prostate cancer: Consensus recommendations from the US Prostate Cancer Conference 2024Bryce, Alan H.; Agarwal, Neeraj; Beltran, Himisha; Hussain, Maha H.; Sartor, Oliver; Shore, Neal; Antonarakis, Emmanuel S.; Armstrong, Andrew J.; Calais, Jeremie; Carducci, Michael A.; Dorff, Tanya Barauskas; Efstathiou, Jason A.; Gleave, Martin; Gomella, Leonard G.; Higano, Celestia; Hope, Thomas A.; Iagaru, Andrei; Morgans, Alicia K.; Morris, David S.; Morris, Michael J.; Petrylak, Daniel P.; Reiter, Robert E.; Rettig, Matthew B.; Ryan, Charles J.; Sellinger, Scott B.; Spratt, Daniel E.; Srinivas, Sandy; Tagawa, Scott T.; Taplin, Mary-Ellen; Yu, Evan Y.; Zhang, Tian; Mckay, Rana R.; Koo, Phillip J.; Crawford, E. David Share Save Share Save Share Save Share Save Share Save 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
